Each year in Europe more than 550,000 patients are diagnosed with breast cancer, of whom 70% have estrogen receptor (ER)-positive disease¹; more than 147,000 breast cancer patients in Europe die annually from the disease²

新加坡2023年9月13日 /美通社/ -- 美纳里尼亚太公司与安斯泰来制药集团（简称“安斯泰来”）达成长期独家许可合作关系，在中国台湾开发、生产和商业化口服Janus激酶(JAK)抑制剂施觅福® 50 mg和100 mg片剂（通用名：氢溴酸吡西替尼，peficitinib hydrobromide），用于治疗类风湿性关节炎。施觅福® 已在中国台湾获得批准，其物质组成专利保护期至2032年。

Each year in Europe more than 550,000 patients are diagnosed with breast cancer, of whom 70% have estrogen receptor (ER)-positive disease¹; more than 147,000 breast cancer patients in Europe die annually from the disease²

FLORENCE, July 6th, 2023 – Yesterday evening, the grand finale of the XXVII edition of the Menarini International Fair Play Awards was warmly greeted by over one thousand spectators at the Roman Theatre in Fiesole. The event, organised by the Menarini Fair Play Foundation and focused on the culture of fair play and respect in sport, drew to a close for the first time on this magnificent stage. Headlining the event were the winners of the 2023 edition, internationally renowned sports legends, shining examples of a healthy approach to competition, both in sporting events and life.

2023年6月26日，中国上海 -- 美纳里尼今日宣布，旗下第二代非镇静性的长效抗组胺药物力敏能®（通用名：比拉斯汀片）正式获国家药品监督管理局（NMPA）批准上市，适用于12岁及以上青少年和成年人荨麻疹的对症治疗。力敏能®获批后，将为中国慢性特发性荨麻疹患者带来新的治疗选择，以更高品质的诊疗优势满足患者的未尽之需，引领中国荨麻疹诊疗新时代。

ROME, June 19th, 2023 - The winners of the XXVII annual Fair Play Menarini International Awards are no longer a secret. This morning at the CONI Hall of Honour, a press conference was held to present the 2023 edition of the awards, scheduled from July 3rd to 5th in Florence and Fiesole. In the presence of Giovanni Malagò, President of the Italian National Olympic Committee (CONI), the Fair Play Menarini Foundation unveiled the list of this year’s winners to be celebrated at the event which has promoted the values of ethics, loyalty and respect through the example of Italian and international sport legends since 1997.